ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,758, issued on July 22, was assigned to MENDUS B.V. (Leiden, Netherlands).

"Use of leukemia-derived cells in ovarian cancer vaccines" was invented by Erik Hans Manting (Leiden, Netherlands), Satwinder Kaur Singh (Leiden, Netherlands) and Jeroen Rovers (Leiden, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods for treating a progressive ovarian cancer using an allogeneic leukemia-derived cell. Also provided are immunogenic compositions comprising an allogeneic leukemia-derived cell, and pharmaceutical compositions and formulations thereof."

The patent was filed on June 29, 2021, under Application No. ...